Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 2, 2019

View Archived Issues

Umbralisib plus ibrutinib demonstrate safety and activity in patients with leukemia and lymphoma

Methylscape alteration of DNA physicochemical properties can be applied for cancer diagnostic assays

Discovery of osimertinib analogue that selectively inhibits EGFR for NSCLC treatment

Novel selective azaindole TGF-beta receptor kinase inhibitors may improve immuno-oncology therapy

AOH-1160 demonstrates promising anticancer activity without significant toxicity in vivo

Sleeping sickness parasite can make its own sugar

Genetic diversity makes for better Alzheimer's model

ST-8116 demonstrates promising antitumor activity in preclinical models of colon cancer

Epigenetic analysis boosts malaria pathogenesis understanding

Patient enrollment ongoing in phase I study of BOS-172738

NicOx presents new compounds for eye disorders

Chiesi Farmaceutici patents new MAPK 14 inhibitors

Cadila Healthcare synthesizes NLRP3 inhibitors

Hanmi Science describes KDM1A inhibitors

Dosing begins in phase III study of Tyvyt for first-line esophageal squamous cell carcinoma

New PDE9 inhibitors presented by Merck & Co.

ALCAM-EGFR axis discovered as therapeutic target in multiple myeloma

BioCryst doses first patient in phase I trial of intravenous galidesivir

Cybrexa selects CBX-11 as lead clinical development candidate

Arcturus Therapeutics nominates ARCT-810 as development candidate for OTC deficiency

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...